John Shiver
Corporate Officer/Principal bei IGM BIOSCIENCES, INC.
Aktive Positionen von John Shiver
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 01.08.2021 | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.09.2018 | - |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Berater | - | - |
Karriereverlauf von John Shiver
Ehemalige bekannte Positionen von John Shiver
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ICOSAVAX, INC. | Direktor/Vorstandsmitglied | 05.01.2022 | 19.02.2024 |
Independent Dir/Board Member | 05.01.2022 | 19.02.2024 | |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Sanofi Pasteur VaxDesign Corp.
Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - |
Ausbildung von John Shiver
University of Florida | Doctorate Degree |
Wofford College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
President | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IGM BIOSCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Sanofi Pasteur VaxDesign Corp.
Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |
- Börse
- Insiders
- John Shiver
- Erfahrung